• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 439516 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413921037 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413921037 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Valeant Pharmaceuticals International: 52-Week High Recently Eclipsed (VRX)

Published on Fri, 02/08/2013 - 15:25
By Mallory Stone

Valeant Pharmaceuticals International (NYSE:VRX) traded today at a new 52-week high of $67.98. This new high was reached on below average trading volume as 576,000 shares traded hands, while the average 30-day volume is approximately 1.4 million shares.

Valeant Pharmaceuticals International share prices have moved between a 52-week high of $67.98 and a 52-week low of $42.47 and are now trading 59% above that low price at $67.71 per share. The 200-day and 50-day moving averages have moved 0.43% higher and 1.50% higher over the past week, respectively.

Valeant Pharmaceuticals International has overhead space with shares priced $67.71, or 6.1% below the average consensus analyst price target of $72.13. The stock should find initial support at its 50-day moving average (MA) of $61.45 and further support at its 200-day MA of $54.13.

Valeant Pharmaceuticals International is a research-based, specialty pharmaceutical company that markets its products worldwide. The Company discovers, develops, manufactures, and markets a range of pharmaceutical products, focusing on products in the areas of infectious disease, neurology, and dermatology.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Rentrak Looks to Continue to Trade Above...

Rentrak (NASDAQ:RENT) traded at a new 52-week high today of $76.50. So far today appro ...

Watch for Continued Gains in Shares of O...

Shares of O'Reilly Automotive (NASDAQ:ORLY) traded today at $158.93, breaking its 52-we ...

Netease.com: The Winning Streak Continue...

Netease.com (NASDAQ:NTES) traded at a new 52-week high today of $94.97. This new high ...

Watch for Continued Gains in Shares of N...

Shares of Nautilus (NYSE:NLS) traded at a new 52-week high today of $13.41. This new h ...

Watch for Continued Gains in Shares of M...

Micron Technology (NASDAQ:MU) traded at a new 52-week high today of $30.93. This new h ...

Monster Worldwide Looks to Continue to T...

Monster Worldwide (NASDAQ:MNST) traded today at a new 52-week high of $99.05. So far t ...

Watch for Continued Gains in Shares of L...

Landstar System (NASDAQ:LSTR) traded at a new 52-week high today of $74.02. So far tod ...

Shares of Kilroy Realty Rise to a New 52...

Shares of Kilroy Realty (NYSE:KRC) traded at a new 52-week high today of $64.36. This ...